Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer.

Halabi S, Guo S, Luo B, Yu C, Knutson TP, Kobilka A, Lyman J, Beltran H, Antonarakis ES, Galsky MD, Rosenberg JE, Ryan CJ, Small EJ, Kelly WK, Morris MJ, Page D, Dehm SM, Armstrong AJ

Open source

DOI
10.1016/j.eururo.2025.07.011
Published
2026 Apr
Container
European urology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eururo.2025.07.011,
  title = {Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer.},
  author = {Halabi S and Guo S and Luo B and Yu C and Knutson TP and Kobilka A and Lyman J and Beltran H and Antonarakis ES and Galsky MD and Rosenberg JE and Ryan CJ and Small EJ and Kelly WK and Morris MJ and Page D and Dehm SM and Armstrong AJ},
  year = {2026},
  journal = {European urology},
  doi = {10.1016/j.eururo.2025.07.011},
  url = {https://doi.org/10.1016/j.eururo.2025.07.011}
}

RIS

TY  - JOUR
TI  - Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer.
AU  - Halabi S
AU  - Guo S
AU  - Luo B
AU  - Yu C
AU  - Knutson TP
AU  - Kobilka A
AU  - Lyman J
AU  - Beltran H
AU  - Antonarakis ES
AU  - Galsky MD
AU  - Rosenberg JE
AU  - Ryan CJ
AU  - Small EJ
AU  - Kelly WK
AU  - Morris MJ
AU  - Page D
AU  - Dehm SM
AU  - Armstrong AJ
PY  - 2026
JO  - European urology
DO  - 10.1016/j.eururo.2025.07.011
UR  - https://doi.org/10.1016/j.eururo.2025.07.011
ER  - 

APA

S, H., S, G., B, L., C, Y., TP, K., A, K., J, L., H, B., ES, A., MD, G., JE, R., CJ, R., EJ, S., WK, K., MJ, M., D, P., SM, D., & AJ, A. (2026). Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer.. European urology. https://doi.org/10.1016/j.eururo.2025.07.011

Source records